Transfer and scale

Area: definition. Apply the shared measurement protocol.

Estimated progress toward AI-managed chemistry

30% complete — judgment-based estimate as of November 7, 2026. Confidence: low. The scale starts at 0% before ChatGPT's public release in 2022 and ends at 100% when AI manages the field's continuing advancement without human participation. This rates the outcome's contribution to that transition, not the percentage of tasks solved, a measured fraction of the field, or time remaining.

The shared scoring rubric uses five equally weighted dimensions: execution, breadth, agenda-setting, validation, and sustained autonomous improvement. Points for this outcome are 10 + 5 + 5 + 5 + 5 = 30/100, in that order; each dimension has a maximum of 20. These component judgments make the estimate inspectable, but are not independently measured scores.

Reason for the estimate: An eightfold laboratory scale-up provides concrete transfer evidence. Small-scale demonstrations do not establish unseen-family success or autonomous industrial process development. The dated baseline below supplies the findings and source links used for this assessment. Unmeasured components receive no demonstrated-progress credit; missing evidence does not prove a missing capability.

What would move the score: Hold out substrate families; repeat accepted routes at increasing batch sizes, measuring yield, purity and between-batch variability. Higher autonomy scores additionally require AI to select worthwhile work, validate results and improve the process over repeated cycles without human research management, repair or adjudication. Lower the score if replication fails, quality regresses or previously hidden human assistance is found. Preserve this dated estimate when adding future assessments.

Measurement and acceptance rule

Success on unseen substrate families and retention of yield, purity, and reproducibility at increased scale.

Evidence requirements

Archive experimental protocols, analytical data, unsuccessful trials, instrument logs, and human interventions. Require independent execution of claimed new routes. Evaluate chemical identity and mass balance rather than accepting plausible descriptions. Compare with both expert chemists and established optimization methods under equal experimental budgets.

Related milestones

See the area's proposed milestones. Proposed targets are distinct from the dated evidence below.

Baseline as of November 7 2026

Status: Multi-case demonstration; industrial-scale retention unknown. Sources accessed November 7, 2026. This is a documentary baseline, not an independent replication or an assertion of the worldwide best result. An unknown measurement is not zero.

Dated findings

2026 publication: Case study 3 was scaled eightfold to 1 mmol, yielding isolated product at 52% yield and 64% deuterium incorporation. RoboChem-Flex, Nature Synthesis.

Interpretation and tracking value

This is laboratory scale, not industrial manufacturing or a held-out substrate-family test. Scale-up is measured, broad transfer remains unquantified.

Next comparable measurement

Hold out substrate families; repeat accepted routes at increasing batch sizes, measuring yield, purity and between-batch variability. Preserve this dated observation; append future results with their model/system version, denominator, budget and evidence level rather than overwriting it.